About US
Contact us
-
Novartis, slammed by Korean scandal, tweaks its ethics, compliance policiesRocked by a corruption scandal in Korea and facing a kickbacks probe in Greece, Novartis says it's strengthening and simplifying its global ethics and compliance approach. The Swiss drug giant is aim2017/5/25
-
Rheumatoid Arthritis Biosimilars: Regulatory and Clinical ConsiderationsPosted by Alicia M. Baker, Director, Global Regulatory Affairs Strategy, Covance Three biosimilars for rheumatoid arthritis (RA) were approved by the FDA last year, but the regulatory pathway in th2017/5/25
-
J&J strikes settlement in ‘phantom’ Motrin recall suitJohnson & Johnsonhas finally gotten a consumer health care fiasco behind it when it agreed this week to pay Oregon $400,000 to settle a suit stemming from its efforts years ago to retrieve faulty2017/5/24
-
Johnson & Johnson appeal of $72M talc verdict could hinge on Bristol-Myers Squibb's SCOTUS caseReeling from multiple court defeats over claims the company’s talcum powders caused ovarian cancer, Johnson & Johnson attorneys are taking their arguments to appeals court, hoping to turn back lia2017/5/24
-
Shadowed by nearly $30B in debt, Valeant's $50M guidance raise looks pretty paltry, analyst saysFaced with a crippling pile of debt, Valeant on Tuesday slightly increased its 2017 earnings guidance, one small positive development as it works to rebound from its noted downfall. The Canadian drug2017/5/23
-
U.S. prosecutors zero in on J&J marketing, targeting top immunology, hep C medsAs if Johnson & Johnson didn’t have enough legal woes already, with the mounting number of cases claiming alinkbetween its talcum powder and ovarian cancer, the pharma giant now faces a fresh roun2017/5/23
-
Louisiana wants HHS head Price to sidestep Gilead hepatitis C patents: reportUnder great pressure to make an M&A move and grappling with crashing hepatitis C sales, Gilead Sciences could soon find itself facing another challenge, this time from the U.S. government. Loui2017/5/22
-
J&J loses latest talc verdict and ordered to pay $110MIn what has turned out to be a mixed week in court for Johnson & Johnson, the drugmakertook a took a damaging hit late Thursday as a St. Louis jury awarded the largest verdict to date in the ongoi2017/5/22
-
Pfizer faces renewed bid for Xalkori royalties as appeals panel revives NYU lawsuitPfizer thought it had escaped the prospect of paying tens of millions in royalties on its lung cancer drug Xalkori. But an appeals court resurrected New York University's claims for a share of the dru2017/5/19
-
J&J, Bayer prevail in bellwether Xarelto trialThe first trial over blockbuster Xarelto’s bleeding risks has swung in Bayer and Johnson & Johnson’s favor as a New Orleans jury decided on Wednesday the Big Pharma companies didn’t fail to warn a2017/5/19